S. Nakawatase

Efficacy of sodium–glucose cotransporter 2 inhibitors in heart failure patients with low body mass index

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a cornerstone therapy for patients with heart failure (HF), improving clinical outcomes across the ejection fraction spectrum. However, in real-world practice, their use is often withheld in patients with low body mass index (BMI) due to concerns about potenti...

Two-year clinical outcomes of jetstream atherectomy followed by drug-coated balloon angioplasty for severely calcified femoropopliteal lesions.